Aveir VR Coverage With Evidence Development Post-Approval Study

Study overview

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Abbott Medical Devices,

Grant Kim, STUDY_DIRECTOR, Abbott

Study Record Dates

2028-01-01